These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8246241)

  • 1. 18F-labeled benzamides for studying the dopamine D2 receptor with positron emission tomography.
    Mach RH; Luedtke RR; Unsworth CD; Boundy VA; Nowak PA; Scripko JG; Elder ST; Jackson JR; Hoffman PL; Evora PH
    J Med Chem; 1993 Nov; 36(23):3707-20. PubMed ID: 8246241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET imaging studies of dopamine D2 receptors: comparison of [18F]N-methylspiperone and the benzamide analogues [18F]MABN and [18F]MBP in baboon brain.
    Mach RH; Ehrenkaufer RL; Greenberg JH; Shao L; Morton TE; Evora PH; Nowak PA; Luedtke RR; Cohen D; Reivich M
    Synapse; 1995 Mar; 19(3):177-87. PubMed ID: 7784958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two fluorine-18 labeled benzamide derivatives that bind reversibly to dopamine D2 receptors: in vitro binding studies and positron emission tomography.
    Mach RH; Nader MA; Ehrenkaufer RL; Line SW; Smith CR; Luedtke RR; Kung MP; Kung HF; Lyons D; Morton TE
    Synapse; 1996 Dec; 24(4):322-33. PubMed ID: 10638823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of [18F]4-fluorobenzyl iodide (FBI) in PET radiotracer synthesis: model alkylation studies and its application in the design of dopamine D1 and D2 receptor-based imaging agents.
    Mach RH; Elder ST; Morton TE; Nowak PA; Evora PH; Scripko JG; Luedtke RR; Unsworth CD; Filtz T; Rao AV
    Nucl Med Biol; 1993 Aug; 20(6):777-94. PubMed ID: 8401379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of (125)I-IABN, a novel azabicyclononane benzamide selective for D2-like dopamine receptors.
    Luedtke RR; Freeman RA; Boundy VA; Martin MW; Huang Y; Mach RH
    Synapse; 2000 Dec; 38(4):438-49. PubMed ID: 11044891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of N-alkylation on the affinities of analogues of spiperone for dopamine D2 and serotonin 5-HT2 receptors.
    Mach RH; Jackson JR; Luedtke RR; Ivins KJ; Molinoff PB; Ehrenkaufer RL
    J Med Chem; 1992 Feb; 35(3):423-30. PubMed ID: 1531364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y; Hammond PS; Whirrett BR; Kuhner RJ; Wu L; Childers SR; Mach RH
    J Med Chem; 1998 Jun; 41(13):2361-70. PubMed ID: 9632369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 5-[18F]fluoropropylepidepride as a potential PET radioligand for imaging dopamine D2 receptors.
    Kessler RM; Votaw JR; de Paulis T; Bingham DR; Ansari MS; Mason NS; Holburn G; Schmidt DE; Votaw DB; Manning RG
    Synapse; 1993 Nov; 15(3):169-76. PubMed ID: 8278895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and biological evaluation of 18F-labeled benzamide analogs as potential dopamine D2 receptor ligands.
    Kiesewetter DO; Kawai R; Chelliah M; Owens E; McLellan C; Blasberg RG
    Int J Rad Appl Instrum B; 1990; 17(4):347-56. PubMed ID: 2143753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.
    Slifstein M; Hwang DR; Huang Y; Guo N; Sudo Y; Narendran R; Talbot P; Laruelle M
    Psychopharmacology (Berl); 2004 Sep; 175(3):274-86. PubMed ID: 15024551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopyrimidines with high affinity for both serotonin and dopamine receptors.
    Wustrow D; Belliotti T; Glase S; Kesten SR; Johnson D; Colbry N; Rubin R; Blackburn A; Akunne H; Corbin A; Davis MD; Georgic L; Whetzel S; Zoski K; Heffner T; Pugsley T; Wise L
    J Med Chem; 1998 Feb; 41(5):760-71. PubMed ID: 9513604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorine-18-labelled NCQ 115, a selective dopamine D-2 receptor ligand. Preparation and positron emission tomography.
    Halldin C; Högberg T; Farde L
    Nucl Med Biol; 1994 May; 21(4):627-31. PubMed ID: 9234320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET study.
    Werhahn KJ; Landvogt C; Klimpe S; Buchholz HG; Yakushev I; Siessmeier T; Müller-Forell W; Piel M; Rösch F; Glaser M; Schreckenberger M; Bartenstein P
    Epilepsia; 2006 Aug; 47(8):1392-6. PubMed ID: 16922886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, receptor potency, and selectivity of halogenated diphenylpiperidines as serotonin 5-HT2A ligands for PET or SPECT brain imaging.
    Fu X; Tan PZ; Kula NS; Baldessarini R; Tamagnan G; Innis RB; Baldwin RM
    J Med Chem; 2002 May; 45(11):2319-24. PubMed ID: 12014970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor-mediated regulation of striatal cholinergic activity: positron emission tomography studies with norchloro[18F]fluoroepibatidine.
    Ding YS; Logan J; Bermel R; Garza V; Rice O; Fowler JS; Volkow ND
    J Neurochem; 2000 Apr; 74(4):1514-21. PubMed ID: 10737608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of high affinity, aryl-substituted [18F]fluoropropylbenzamides for dopamine D-2 receptor studies.
    Mathis CA; Bishop JE; Gerdes JM; Whitney JM; Brennan KM; Jagust WJ
    Int J Rad Appl Instrum B; 1992 Jul; 19(5):571-88. PubMed ID: 1399687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer.
    Mukherjee J; Yang ZY; Das MK; Brown T
    Nucl Med Biol; 1995 Apr; 22(3):283-96. PubMed ID: 7627142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective, centrally acting serotonin 5-HT2 antagonists. 2. Substituted 3-(4-fluorophenyl)-1H-indoles.
    Andersen K; Perregaard J; Arnt J; Nielsen JB; Begtrup M
    J Med Chem; 1992 Dec; 35(26):4823-31. PubMed ID: 1336054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.